Trial Profile
Expanded Access for LJPC-501
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 12 Mar 2018
Price :
$35
*
At a glance
- Drugs Angiotensin II (Primary)
- Indications Hypotension
- Focus Expanded access; Therapeutic Use
- Sponsors La Jolla Pharmaceutical Company
- 06 Mar 2018 Status changed from recruiting to completed.
- 11 Aug 2017 New trial record